Silicon Valley and Wall Street are pouring billions into AI drug discovery in a high-stakes bet to “solve” disease.

OpenAI has been a central driver of the AI Revolution since ChatGPT's launch in November 2022. Learn more about OpenAI here.

Meta Platforms’ job cuts at its Reality Labs division this past week, where it let go about 10% of the unit, were the first ...

In this weekly Plain Facts compilation, we present to you data-based insights, with easy-to-read charts, to help you delve ...

When Nancy Pelosi makes a move in the stock market, people notice. The former House Speaker has built a reputation for ...

Artificial intelligence (AI) is shaping up to be the most revolutionary technology in at least a decade. Barron's estimates ...

Apple will rely on Google to help finish its efforts to smarten up its virtual assistant Siri and bring other artificial ...

Ai, a "genius" chimpanzee who could recognise more than 100 Chinese characters and the English alphabet, has died aged 49, ...

Larry Page’s apparent Florida move highlights how seriously the ultra-rich are taking a one-time tax aimed at extreme wealth ...

The Bristlemoon Global Fund achieved an 11.9 percent cumulative return since inception despite recent quarterly volatility.

Colin is an Associate Editor focused on tech and financial news. He has more than three years of experience editing, proofreading, and fact-checking content on current financial events and politics.

Google’s Gemini 3 has once again emerged as a formidable rival of OpenAI’s chatbot ChatGPT. The Google chatbot has managed to deliver superior results.